Comparing Delayed Cord Clamping and Umbilical Cord Milking During Elective Cesarean Section for the Neonatal Outcome

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05951348

Enrollment

162

Registered

2023-07-19

Start date

2021-11-11

Completion date

2022-06-20

Last updated

2023-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Umbilical Cord Milking

Keywords

cesarean section, umbilical cord milking, hemoglobin

Brief summary

the study is conducted on the different actions on umbilical cord clamping including immediate cord clamping (ICC) , delayed cord clamping (DCC) for 30 seconds and umbilical cord milking (UCM) for 10-15 seconds in females that are delivered by elective cesarean section , to assess the neonatal outcomes including Hemoglobin and Hematocrit levels after birth in the newborn and the bilirubin level after 72 hrs

Detailed description

the benefit of umbilical cord milking for 10-15 seconds maneuver in cesarean section, that short time can improve the hemoglobin level and prevent anemia in the newborn with improvement of the iron stores for months in infancy without affection on the bilirubin level and the need for phototherapy. This is significant because of the rising rate of cesarean section all over the world make more children are liable for anemia, and by this simple technique it can be prevented.

Interventions

PROCEDUREDelayed cord clamping for 30 seconds

waiting for 30 seconds after delivery of the fetus or milking of the cord in the direction of the fetus 10 times in time frame 10-15 seconds

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

DIAGNOSTIC

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 40 Years

Healthy volunteers

Inclusion criteria

* mother's age (20-40) years. * pregnancy with a healthy singleton * gestational age of 38-41 0/7 weeks * uncomplicated pregnancy

Exclusion criteria

* Any medical or obstetrical complications like hypertension, pre-eclampsia, diabetes any special habits like smoking, and substance abuse * Rh-negative mothers. The fetal

Design outcomes

Primary

Measure	Time frame	Description
hemoglobin level	immediately after the intervention	a blood sample is taken from the umbilical cord of the neonate

Secondary

Measure	Time frame	Description
bilirubin level	72 hours after delivery	trans-cutaneous measurement of the bilirubin level

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026